Tennessee joins states suing OxyContin maker

Tennessee joins states suing OxyContin maker

Tennessee joins states suing OxyContin maker

Slatery leads a multistate group of attorneys general who are investigating manufacturers and distributors and, while not a party, is voluntarily engaging in settlement discussions in connection with the federal opioid multidistrict litigation pending in Cleveland, Ohio, according to the release. If you feel you're struggling with addiction, you can contact them here. An estimated 2.4 million Americans are addicted to narcotics including prescription painkillers and heroin.

Slatery III, along with a bipartisan group of Attorneys General, sued Purdue Pharma today for its unlawful marketing and promotion of OxyContin and other drugs and its role in causing and prolonging the opioid epidemic in Tennessee.

In addition to suing Purdue, Florida Attorney General Pam Bondi included Endo Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Cephalon, Inc., and Allergan plc, and opioid distributors AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation, and Mallinckrodt LLC, in her complaint. "Purdue initiated the expansion of the opioid market that created the opioid crisis", Stenehjem said.

Teva issued a statement in which it emphasized the importance of safely using opioids.

- Falsely representing that Purdue's abuse-deterrent formulation of OxyContin reduces the risks of OxyContin, including the risk of addiction.

Stenehjem estimates Purdue has raked in almost 35 billion dollars from opioids over the years that have taken thousands of lives, numbers he calls unconscionable. A spokeswoman for the office did not say when that lawsuit would be filed.

In 2016, 1,375 Texans died of opioid-related deaths.

Nevada state Attorney General Adam Paul Laxalt speaks at a news conference on a lawsuit against Purdue Pharma, Tuesday, May 15, 2018, in Las Vegas.

The company also repeatedly claimed its opioid products did not have maximum dosage limits, even after doctors raised concerns, saying limits are dependent on side-effects experienced by the patient, the lawsuit alleges. We believe Purdue's conduct has been unconscionable, and we intend to hold the company accountable.

A total of 22 states have now filed actions against one or more opioid drug markers, seeking financial compensation for states' law enforcement and drug treatment expenses.

Related news

[an error occurred while processing the directive]